Last modified: January 10, 2010
Offices[edit]
People[edit]
Web Presences[edit]
- Biotech & Life Sciences
- Pharmaceutical
Industries[edit]
Parent Company[edit]
Acquisitions / Subsidiaries[edit]
Paid Sources[edit]
Keywords[edit]
|
|
Description[edit]
Developing first-in-class Drugs for the cardiometabolic market
InVasc is a clinical stage biopharmaceutical company developing Drugs to treat or prevent cardiometabolic disease. We are currently focused on advancing our to lead Drugs for Chronic Kidney Disease and Atherosclerosis. Cardiovascular and metabolic diseases are the leading causes of morbidity and mortality worldwide, and collectively represent the single largest global market for pharmaceutical drug development with annual sales currently reaching $400 billion.
InVasc Therapeutics was founded in 2006 by three leading researchers at Emory University and Ohio State University with the objective of being new therapeutic alternatives to the market.
Innovation[edit]
Activities[edit]
| Jobs by SimplyHired |
- No jobs were found for this particular company. Please visit the job board to search for more.
| InVasc Job Trends | InVasc Jobs |
- Biotech Showcase 2010 - Presenting Companies (3 subscribers)
This Company is Being Watched in
Recent Updates |
|---|
| InVasc has been added to the Ecosystem. |